IART
Integra LifeSciences Holdings Corporation NASDAQ Listed Aug 16, 1995$13.57
After hrs
$14.03
+0.79%
Mkt Cap $1.1B
52w Low $8.70
62.5% of range
52w High $16.49
50d MA $10.17
200d MA $12.44
P/E (TTM)
-1.6x
EV/EBITDA
-8.4x
P/B
0.8x
Debt/Equity
1.9x
ROE
-49.5%
P/FCF
-30.7x
RSI (14)
—
ATR (14)
—
Beta
1.06
50d MA
$10.17
200d MA
$12.44
Avg Volume
807.7K
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
1100 Campus Road · Princeton, NJ 08540 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | TNS | 0.41 | 0.54 | +31.7% | 13.22 | +0.2% | +5.9% | +2.6% | — | — | — | — |
| Feb 26, 2026 | TNS | 0.79 | 0.83 | +5.1% | 11.33 | -1.9% | +0.4% | +0.4% | -7.9% | -6.8% | -8.3% | — |
| Oct 30, 2025 | TNS | 0.43 | 0.54 | +25.6% | 11.81 | +0.8% | +1.7% | +1.7% | -2.7% | -4.3% | -3.5% | — |
| Jul 31, 2025 | TNS | 0.43 | 0.45 | +4.7% | 13.14 | -3.2% | -6.3% | -6.3% | -4.4% | -3.1% | -5.9% | — |
| May 5, 2025 | TNS | 0.43 | 0.41 | -4.7% | 13.28 | +0.5% | -4.0% | -4.0% | -4.1% | -2.9% | -7.8% | — |
| Feb 25, 2025 | TNS | 0.86 | 0.97 | +12.8% | 24.72 | -0.9% | -4.5% | -4.5% | -6.7% | -6.1% | -9.1% | — |
| Nov 4, 2024 | TNS | 0.39 | 0.41 | +5.1% | 24.12 | +0.2% | +3.3% | +3.3% | +10.7% | +5.8% | +2.7% | — |
| Jul 29, 2024 | TNS | 0.62 | 0.63 | +1.6% | 25.42 | -2.8% | -1.5% | -1.5% | -2.4% | -3.2% | -5.4% | — |
| May 6, 2024 | TNS | 0.55 | 0.55 | +0.0% | 23.14 | -2.2% | +8.4% | +8.4% | +7.6% | +9.3% | +12.3% | — |
| Feb 28, 2024 | TNS | 0.90 | 0.89 | -1.1% | 38.67 | +0.9% | -4.6% | -4.6% | -6.9% | -7.1% | -5.5% | — |
| Oct 25, 2023 | TNS | 0.78 | 0.76 | -2.6% | 35.34 | -0.8% | +0.5% | +0.5% | -3.2% | -0.8% | +1.7% | — |
| Jul 26, 2023 | TNS | 0.57 | 0.71 | +24.6% | 45.55 | +0.1% | -2.2% | -2.2% | -0.1% | -0.2% | -1.3% | — |
| Apr 26, 2023 | BMO | 0.74 | 0.74 | +0.0% | 54.20 | -0.4% | +1.9% | +1.9% | +2.1% | +2.6% | -3.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 | Truist | Maintains | Hold → Hold | — | $11.06 | $10.60 | -4.2% | -0.3% | -2.0% | +0.7% | +0.9% | -4.9% |
| Apr 15 | Argus | Downgrade | Buy → Hold | — | $11.06 | $10.60 | -4.2% | -0.3% | -2.0% | +0.7% | +0.9% | -4.9% |
| Mar 11 | Citigroup | Maintains | Sell → Sell | — | $9.55 | $9.45 | -1.0% | +0.6% | -4.0% | -3.2% | -5.7% | -4.7% |
| Feb 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $11.33 | $11.12 | -1.9% | +0.4% | -7.9% | -6.8% | -8.3% | -12.7% |
| Nov 3 | Truist | Maintains | Hold → Hold | — | $12.01 | $11.77 | -2.0% | -4.3% | -5.9% | -5.1% | -6.6% | +0.2% |
| Oct 31 | JP Morgan | Maintains | Underweight → Underweight | — | $11.81 | $11.90 | +0.8% | +1.7% | -2.7% | -4.3% | -3.5% | -5.0% |
| Oct 31 | Citigroup | Maintains | Sell → Sell | — | $11.81 | $11.90 | +0.8% | +1.7% | -2.7% | -4.3% | -3.5% | -5.0% |
| Oct 15 | Truist | Maintains | Hold → Hold | — | $14.40 | $14.48 | +0.6% | -1.2% | +1.5% | +4.7% | +9.0% | +10.3% |
| Oct 7 | Citigroup | Maintains | Sell → Sell | — | $14.50 | $14.65 | +1.0% | -0.5% | +2.1% | -2.3% | -8.0% | -6.1% |
| May 9 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $12.89 | $12.89 | +0.0% | -5.0% | +6.1% | +4.8% | +0.2% | +0.9% |
| May 6 | JP Morgan | Maintains | Underweight → Underweight | — | $13.28 | $13.34 | +0.5% | -4.0% | -4.1% | -2.9% | -7.8% | +2.9% |
| May 6 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $13.28 | $13.34 | +0.5% | -4.0% | -4.1% | -2.9% | -7.8% | +2.9% |
| Apr 11 | Truist | Maintains | Hold → Hold | — | $17.42 | $17.46 | +0.2% | -2.5% | -4.0% | -7.7% | -9.6% | -9.1% |
| Mar 31 | Argus | Upgrade | Hold → Buy | — | $21.69 | $21.98 | +1.3% | +1.4% | -0.4% | +0.4% | -7.5% | -9.8% |
| Feb 26 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $24.72 | $24.50 | -0.9% | -4.5% | -6.7% | -6.1% | -9.1% | -11.4% |
| Nov 5 | Citigroup | Maintains | Sell → Sell | — | $24.12 | $24.16 | +0.2% | +3.3% | +10.7% | +5.8% | +2.7% | +5.5% |
| Oct 14 | Truist | Maintains | Hold → Hold | — | $19.23 | $19.18 | -0.3% | -0.1% | +1.5% | +3.0% | +2.8% | +3.3% |
| Oct 7 | BTIG | Upgrade | Sell → Neutral | — | $17.00 | $17.21 | +1.2% | +2.5% | +2.9% | +6.5% | +13.4% | +13.1% |
| Oct 7 | BofA Securities | Maintains | Underperform → Underperform | — | $17.00 | $17.21 | +1.2% | +2.5% | +2.9% | +6.5% | +13.4% | +13.1% |
| Oct 1 | Citigroup | Maintains | Sell → Sell | — | $18.17 | $18.03 | -0.8% | -3.7% | -4.7% | -6.7% | -6.4% | -4.1% |
| Aug 28 | BTIG | Maintains | Sell → Sell | — | $20.52 | $20.39 | -0.6% | -0.8% | +0.9% | -0.9% | -6.1% | -5.8% |
| Aug 22 | Citigroup | Maintains | Sell → Sell | — | $21.03 | $21.03 | +0.0% | -3.1% | +0.2% | -0.3% | -2.4% | -3.2% |
| Jul 30 | Truist | Maintains | Hold → Hold | — | $25.42 | $24.70 | -2.8% | -1.5% | -2.4% | -3.2% | -5.4% | -12.1% |
| Jul 30 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $25.42 | $24.70 | -2.8% | -1.5% | -2.4% | -3.2% | -5.4% | -12.1% |
| Jul 30 | BTIG | Downgrade | Neutral → Sell | — | $25.42 | $24.70 | -2.8% | -1.5% | -2.4% | -3.2% | -5.4% | -12.1% |
| Jul 30 | Citigroup | Downgrade | Neutral → Sell | — | $25.42 | $24.70 | -2.8% | -1.5% | -2.4% | -3.2% | -5.4% | -12.1% |
| Jul 16 | Truist | Maintains | Hold → Hold | — | $29.84 | $30.19 | +1.2% | +6.4% | +6.1% | +4.9% | +5.0% | +5.7% |
| Jul 15 | Morgan Stanley | Maintains | Underweight → Underweight | — | $30.01 | $30.21 | +0.7% | -0.6% | +5.8% | +5.5% | +4.3% | +4.4% |
| Jul 10 | Citigroup | Maintains | Neutral → Neutral | — | $28.98 | $29.14 | +0.6% | +1.1% | +5.6% | +3.6% | +3.0% | +9.5% |
| May 22 | Citigroup | Maintains | Neutral → Neutral | — | $27.38 | $27.34 | -0.1% | +2.7% | +4.1% | +3.4% | +5.4% | +8.1% |
| May 7 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $23.14 | $22.63 | -2.2% | +8.4% | +7.6% | +9.3% | +12.3% | +13.3% |
| May 7 | BofA Securities | Maintains | Underperform → Underperform | — | $23.14 | $22.63 | -2.2% | +8.4% | +7.6% | +9.3% | +12.3% | +13.3% |
| May 7 | Truist | Maintains | Hold → Hold | — | $23.14 | $22.63 | -2.2% | +8.4% | +7.6% | +9.3% | +12.3% | +13.3% |
| May 7 | Morgan Stanley | Maintains | Underweight → Underweight | — | $23.14 | $22.63 | -2.2% | +8.4% | +7.6% | +9.3% | +12.3% | +13.3% |
| May 7 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $23.14 | $22.63 | -2.2% | +8.4% | +7.6% | +9.3% | +12.3% | +13.3% |
| Apr 3 | Citigroup | Upgrade | Sell → Neutral | — | $33.52 | $34.80 | +3.8% | +1.1% | +0.8% | +1.4% | +2.7% | +3.3% |
| Mar 1 | Truist | Maintains | Hold → Hold | — | $36.91 | $37.13 | +0.6% | -2.5% | -2.7% | -0.9% | -2.2% | -2.2% |
| Feb 29 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $38.67 | $39.00 | +0.9% | -4.6% | -6.9% | -7.1% | -5.5% | -6.6% |
| Dec 22 | Truist | Maintains | Hold → Hold | — | $44.36 | $44.65 | +0.7% | +0.5% | +0.0% | -1.1% | -1.0% | -1.8% |
| Dec 14 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $42.57 | $43.11 | +1.3% | +2.2% | +0.5% | +0.5% | +2.0% | +1.3% |
| Dec 14 | Truist | Maintains | Hold → Hold | — | $42.57 | $43.11 | +1.3% | +2.2% | +0.5% | +0.5% | +2.0% | +1.3% |
| Dec 5 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $40.38 | $41.92 | +3.8% | +2.8% | +1.4% | +2.3% | +2.2% | +3.0% |
| Oct 26 | Truist | Maintains | Hold → Hold | — | $35.34 | $35.05 | -0.8% | +0.5% | -3.2% | -0.8% | +1.7% | +4.3% |
| Oct 26 | Morgan Stanley | Maintains | Underweight → Underweight | — | $35.34 | $35.05 | -0.8% | +0.5% | -3.2% | -0.8% | +1.7% | +4.3% |
| Aug 24 | Morgan Stanley | Downgrade | Equal Weight → Underweight | — | $42.50 | $42.00 | -1.2% | -3.5% | -2.1% | -0.5% | +1.8% | +2.4% |
| Jul 28 | JMP Securities | Maintains | Outperform → Outperform | — | $44.54 | $44.67 | +0.3% | +2.2% | +2.1% | +0.9% | -0.1% | +0.5% |
| Jul 19 | Truist | Maintains | Hold → Hold | — | $43.64 | $43.83 | +0.4% | +3.0% | +2.1% | +3.9% | +4.7% | +5.3% |
| Jul 12 | Jefferies | Upgrade | Hold → Buy | — | $41.30 | $42.82 | +3.7% | +3.9% | +4.1% | +4.0% | +4.2% | +5.7% |
| Jun 8 | Argus | Downgrade | Buy → Hold | — | $41.25 | $40.51 | -1.8% | -0.7% | -1.5% | -1.1% | +0.1% | -1.3% |
| May 31 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $38.27 | $38.20 | -0.2% | -0.8% | +0.4% | +1.8% | +3.6% | +6.3% |
No insider trades available.
8-K · 5.02
!!! Very High
Integra LifeSciences Holdings Corporation -- 8-K 5.02: Executive Change
Integra LifeSciences (IART) appointed Dr. Stuart Essig as an officer, signaling potential organizational restructuring that could affect operational leadership and strategic direction.
May 5
8-K · 2.02
!! High
Integra LifeSciences Holdings Corporation -- 8-K 2.02: Earnings Results
Integra LifeSciences reported Q1 2026 financial results on May 5, 2026, with detailed operating performance and financial condition information available in the company's press release.
May 5
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
The extension of the asset-backed lending facility to 2029 reduces near-term refinancing risk and provides BNS and IART with enhanced operational flexibility, supporting continued working capital financing stability.
Apr 15
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
The company disclosed investor presentation materials on March 17, 2026, suggesting upcoming investor meetings or conferences that could signal strategic updates or capital plans worth monitoring.
Mar 17
8-K
Integra LifeSciences Holdings -- 8-K Filing
Integra LifeSciences (IART) disclosed adjusted EPS guidance without GAAP reconciliation due to unpredictability of certain expense items, limiting investor transparency on earnings quality.
Feb 26
8-K · 5.02
!!! Very High
Kyverna Therapeutics, Inc. -- 8-K 5.02: Executive Change
Kyverna Therapeutics appointed Andrew Miller as a Class III director, expanding its board composition to strengthen governance and potentially bringing new strategic expertise to the company.
Feb 24
8-K · 5.02
!!! Very High
Piper Sandler Companies -- 8-K 5.02: Executive Change
Piper Sandler Companies appointed Stuart M. Essig as a director, expanding its board leadership potentially with his industry expertise.
Feb 4
Data updated apr 25, 2026 2:40pm
· Source: massive.com